VEKLURY is a drug used for the treatment of coronavirus disease 2019 (COVID-19) in certain patients. It is specifically indicated for adults and adolescents (aged 12 years and older with body weight at least 40 kg) who have pneumonia requiring supplemental oxygen. Additionally, it has also been approved for the treatment of mild to moderate COVID-19 in pediatric patients above 28 days of age and weighing at least 3kg. VEKLURY is an antiviral medication that works by inhibiting the replication of SARS-CoV-2, the virus that causes COVID-19.
7 answers
charlotte_clark_doctor
Mon Nov 04 2024
It is utilized to treat COVID-19 in adult patients, addressing their viral infection effectively.
CryptoWizardry
Mon Nov 04 2024
The medicine is also suitable for pediatric use, catering to children who weigh at least 3 pounds.
CryptoVisionary
Mon Nov 04 2024
Hospitalized adults and children can benefit from VEKLURY as part of their treatment plan.
MysticGlider
Mon Nov 04 2024
For those who are not hospitalized but have mild-to-moderate symptoms of COVID-19, VEKLURY offers a therapeutic solution.
Chiara
Mon Nov 04 2024
VEKLURY serves as a prescription medication designed for specific therapeutic purposes.